460 related articles for article (PubMed ID: 23821689)
1. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.
Fawole A; Daw HA; Crowther MA
Cleve Clin J Med; 2013 Jul; 80(7):443-51. PubMed ID: 23821689
[TBL] [Abstract][Full Text] [Related]
2. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
[TBL] [Abstract][Full Text] [Related]
3. [New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
Oberhofer E
MMW Fortschr Med; 2015 Jan; 157(1):24. PubMed ID: 25743289
[No Abstract] [Full Text] [Related]
4. New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
Tran H; Joseph J; Young L; McRae S; Curnow J; Nandurkar H; Wood P; McLintock C
Intern Med J; 2014 Jun; 44(6):525-36. PubMed ID: 24946813
[TBL] [Abstract][Full Text] [Related]
5. [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].
Nagler M; Wuillemin W
Ther Umsch; 2012 Nov; 69(11):650-6. PubMed ID: 23117668
[TBL] [Abstract][Full Text] [Related]
6. The new oral anticoagulants in clinical practice.
Gonsalves WI; Pruthi RK; Patnaik MM
Mayo Clin Proc; 2013 May; 88(5):495-511. PubMed ID: 23639500
[TBL] [Abstract][Full Text] [Related]
7. Management of hemorrhage with the target-specific oral anticoagulants.
Pluym M; Howell G
Hosp Pract (1995); 2014 Aug; 42(3):75-83. PubMed ID: 25255409
[TBL] [Abstract][Full Text] [Related]
8. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
Gong IY; Kim RB
Can J Cardiol; 2013 Jul; 29(7 Suppl):S24-33. PubMed ID: 23790595
[TBL] [Abstract][Full Text] [Related]
9. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
Fenger-Eriksen C; Münster AM; Grove EL
Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468
[TBL] [Abstract][Full Text] [Related]
10. [General characteristics of the new oral anticoagulants].
Gegu M; Chevalet P; Piloquet FX; Berrut G; De Decker L
Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):4-9. PubMed ID: 24463058
[TBL] [Abstract][Full Text] [Related]
11. Perioperative management of patients on new oral anticoagulants.
Lai A; Davidson N; Galloway SW; Thachil J
Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
[TBL] [Abstract][Full Text] [Related]
12. Managing new oral anticoagulants in the perioperative and intensive care unit setting.
Levy JH; Faraoni D; Spring JL; Douketis JD; Samama CM
Anesthesiology; 2013 Jun; 118(6):1466-74. PubMed ID: 23416382
[TBL] [Abstract][Full Text] [Related]
13. The laboratory and the new oral anticoagulants.
Tripodi A
Clin Chem; 2013 Feb; 59(2):353-62. PubMed ID: 23043068
[TBL] [Abstract][Full Text] [Related]
14. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
15. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
16. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
17. The novel anticoagulants: the surgeons' prospective.
Shamoun FE; Martin EN; Money SR
Surgery; 2013 Mar; 153(3):303-7. PubMed ID: 23218887
[TBL] [Abstract][Full Text] [Related]
18. [Bleeding and surgery in the treatment with new oral anticoagulants. The management can be complicated by the lack of specific antidotes].
Dalén M; Hjemdahl P; Holmström M; Ivert T
Lakartidningen; 2014 Jun 11-17; 111(24):1064-8. PubMed ID: 25129916
[No Abstract] [Full Text] [Related]
19. Novel oral anticoagulants: a review of the literature and considerations in special clinical situations.
Akwaa F; Spyropoulos AC
Hosp Pract (1995); 2013 Feb; 41(1):8-18. PubMed ID: 23466963
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists.
Levy JH
Clin Lab Med; 2014 Sep; 34(3):443-52. PubMed ID: 25168936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
